Trending...
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- Consortium Media Appoints Jennifer Curtis-Neves as President of Consortium Media
A plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity.
MILPITAS, Calif. - Californer -- Cluster of differentiation 38 (CD38), also known as cyclic ADP ribose hydrolase or ADP-ribosyl cyclase is a multifunctional enzyme that catalyzes the synthesis and hydrolysis of Nicotinamide Adenine Dinucleotide (NAD) to Nicotinamide and ADP-ribose (ADPR). Additionally, CD38 generates second messengers, cyclic ADP-ribose using NAD as the substrate. Due to its role in NAD+ metabolism, the study of CD38 and its functions has been of great importance.
It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+, etc. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc. BioVision's CD38 (Cyclase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm.
More on The Californer
In the presence of potential CD38 cyclase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 cyclase activity by Quercetin. IC50 was calculated to be 5.2 ± 0.8 μM. Assay was performed following the kit protocol.
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2102 https://bit.ly/30wP71F
It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+, etc. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc. BioVision's CD38 (Cyclase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 cyclase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm.
More on The Californer
- The Iconic Cops TV Show Is Now Streaming on AwepraTV
- Matt Ox Releases New Visual Content Highlighting Artistic Growth and Collaboration
- Silva Construction Unveils 2026 Design Trends
- California: Governor Newsom announces appointments 12.12.2025
- Interpreters Unlimited Helps NORAD Track Santa in More Languages Than Ever Before
In the presence of potential CD38 cyclase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 cyclase activity by Quercetin. IC50 was calculated to be 5.2 ± 0.8 μM. Assay was performed following the kit protocol.
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2102 https://bit.ly/30wP71F
Source: BioVision Inc
Filed Under: Biotech
0 Comments
Latest on The Californer
- Stay Connected Cell Service Optional
- Ventura College Foundation Distributes Record $1.16 Million in Direct Student Support
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
- 'A Hot Set' Launches New Feature: The Best and Worst of Soap Operas
- The Best Cartier-Inspired Jewellery to Buy in 2025 — Just in Time for the Ermoleve Christmas Sale
- No Tipping Car Wash in Northridge CA
- California state parks are for everyone, while Trump turns national parks into his vanity project
- California: Trump's AI executive order advances corruption, not innovation
- Governor Newsom deploys California resources to Washington to support flood response efforts
- IODefi Introduces New Web3 Infrastructure Framework as XRP Ledger Development Gains Global Attention
- Relief Alliance Skid Row Outreach Brings Celebrities and Volunteers Together for Community Impact
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- Car Wash in Northridge Under $10
- Only 3 Spots Left for Rise Within: Wellness Retreat Los Cabos – January 2026
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- bisco industries New Authorized Line: SKF Aerospace
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Baby Boomers: The Perfect Cash Buyers in Today's Market
- Stray Theories Unveils Falter, an Atmospheric Passage Through the Spaces Between Doubt and Hope
- Holiday Decorations Most Likely to Cause Injuries